Versant Capital Management »

Cognition Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7k 2.0k 1.35

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vaneck Gold Miners Etf Etf (GDX)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Cognition Therapeutics

BIOS Capital Management
Davenport & Co
Vanguard Group
Tang Capital Management
Chescapmanager
BlackRock
Jane Street
Renaissance Technologies
Geode Capital Management
Hilton Capital Management
Millennium Management
State Street Corporation
Voss Capital
Graham Capital Management
American Financial Group

View all funds holding Cognition Therapeutics